Population-Scale Targeted Resequencing for Genes and Genomic Regions

Overview

When genes, loci, or candidate intervals are already known, a targeted resequencing service concentrates sequencing on those predefined regions instead of distributing reads across the entire genome. This makes it practical to investigate common and rare variants, compare allele frequencies, and evaluate regional haplotypes across hundreds to thousands of samples while keeping the resulting dataset focused and manageable.

CD Genomics supports population-scale studies that begin with gene lists, genomic coordinates, BED files, GWAS loci, QTL candidate intervals, exons, or regulatory regions. Project design can cover target definition, enrichment strategy, sequencing, cohort-level quality control, variant analysis, and study-ready outputs. The final assay configuration and sequencing allocation are set according to target size, genome context, sample quality, cohort structure, and the biological question.

Focus effort on known targets: limiting sequencing to relevant regions increases the usable information collected per target, so large cohorts can be evaluated without generating whole-genome-scale data for every sample.
Keep cohort results comparable: one coordinated design and shared QC framework make it easier to distinguish biological differences from target-coverage or batch effects.
Move from discovery to validation: candidate regions from WGS, GWAS, QTL mapping, or prior literature can be converted into a defined follow-up study with variant and population-level outputs.

Planning a large-cohort follow-up study? Prepare your species, reference assembly, cohort structure, target list, and expected analyses for a project-design discussion.

Target genes and genomic regions moving through targeted enrichment and cohort sequencing to variant and haplotype outputs. Figure 1: Targeted resequencing connects a defined target list with focused sequencing and population-level interpretation across a large cohort.

What Is Targeted Resequencing?

Targeted resequencing is next-generation sequencing of genomic regions selected before library enrichment or amplification. Unlike WGS, which surveys the full genome, or WES, which is limited to annotated coding exons, a custom design can focus on the exact genes, exons, regulatory regions, candidate loci, or coordinates that answer the study question.

The value is not simply deeper sequencing. The important advantage is controlled scope: reads are concentrated on relevant targets, which reduces unnecessary data and supports coordinated analysis across many samples. In practice, this is useful after discovery work has already narrowed the search space and the next decision depends on validating variants, estimating population frequencies, or comparing the same regions across groups.

Target Options Built Around the Research Question

Target Input	Typical Use	Research Benefit
Candidate genes or exons	Follow-up of prior functional evidence or phenotype-linked genes	Concentrates analysis on interpretable gene regions, reducing the number of unrelated variants that require review.
GWAS loci or fine-mapping intervals	Targeted sequencing after association discovery	Adds sequence-level variation around associated loci, helping researchers move from a signal to candidate variants and regional haplotypes.
QTL candidate intervals	Trait mapping follow-up in plant or animal populations	Tests the same candidate interval across a broader cohort, supporting cross-population validation and marker prioritization.
Regulatory or noncoding regions	Promoters, enhancers, conserved elements, and other defined features	Extends the study beyond coding sequence when the hypothesis depends on regulatory variation that WES would not capture.
Custom genomic coordinates	BED files or assembly-specific interval lists	Preserves the investigator's exact discovery boundaries, which is important when regions do not align with standard gene annotations.

Hybridization Capture or Amplicon-Based Targeting?

Hybridization capture uses complementary probes to enrich many dispersed or extended genomic regions from a sequencing library. Its flexible target architecture can accommodate genes, exons, and noncoding intervals in one design, so it is often a strong fit when the study spans numerous or irregular targets.

Amplicon-based targeting uses multiplex PCR to amplify defined regions. It can be efficient for compact, well-characterized targets and very large sample counts, so the method may be preferable when the total target set is small and primer design is straightforward. Repetitive sequence, GC extremes, nearby homologs, target length, and expected variant types all influence the choice; neither method is universally superior.

Population-Scale Workflow with Cohort QC

A large-cohort project succeeds when target design, sample processing, and analysis use the same coordinate system and QC logic from the beginning. The workflow below treats each sample as part of a cohort rather than as an isolated sequencing library, which helps prevent technical variation from being mistaken for population variation.

1. Study and target review

We review the biological objective, reference assembly, target list, population groups, sample count, and intended downstream analyses. This connects assay scope to the final decision the study must support, rather than treating every requested coordinate as equally informative.

2. Target-design feasibility assessment

Candidate regions are assessed for mappability, repeats, GC composition, paralogous sequence, interval boundaries, and compatibility with the selected targeting method. Identifying difficult regions before production reduces avoidable coverage gaps and shows where orthogonal validation or an alternative method may be needed.

3. Sample and library quality control

DNA identity, quantity, purity, and integrity are evaluated using project-appropriate checks before library preparation. Applying consistent acceptance logic across the cohort reduces batch imbalance and limits downstream missingness caused by uneven starting material.

4. Target enrichment and sequencing

Libraries are enriched by the agreed capture or amplicon strategy and sequenced with allocation matched to target size and analysis goals. Because allocation is based on the study design, coverage can be interpreted against the variants and cohort comparisons that matter rather than against a generic depth claim.

5. Data processing and cohort harmonization

Reads are checked, aligned to the confirmed reference, and evaluated for target coverage, uniformity, mapping behavior, and sample-level consistency. Variant processing then follows a shared cohort framework, which improves comparability among groups and makes exclusions traceable.

6. Review and delivery

Results are reviewed against target completeness, sample-level QC, and the agreed analysis scope before delivery. This links each file and figure to a documented method and QC record, making the dataset easier to use in downstream association, frequency, or haplotype analyses.

Six-step targeted resequencing workflow from target review and sample quality control to enrichment, sequencing, cohort analysis, and delivery. Figure 2: The cohort workflow links every technical step to a decision point and a documented output.

Quality Control and Cohort Harmonization

Useful targeted data require more than a high average depth. Sample-level callability, per-target coverage, on-target behavior, uniformity, missingness, and cross-batch consistency show whether a locus can be compared fairly across the cohort. These measurements help researchers identify samples or regions that need cautious interpretation before frequency or association analysis.

The published example below shows why coverage should be viewed across all targets and samples rather than summarized as one number.

Figure 3: Original evidence summary showing why target coverage should be reviewed across samples and loci, based on the independent study by Oh et al. (2023).

Sample Requirements and Project Inputs

The most useful submission package combines biological samples with target and cohort metadata. Exact DNA requirements depend on species, genome complexity, target architecture, and the selected library strategy, so final acceptance criteria should be confirmed during project design rather than inferred from a generic threshold.

Input	What to Provide	Review Point	Why It Matters
Genomic DNA	DNA from the study species, submitted in the agreed container and buffer	Quantity, purity, integrity, contamination risk, and sample consistency	Comparable starting material reduces uneven library performance across groups.
Source material	Tissue or another source type when extraction is included in scope	Species, preservation method, storage history, and extraction feasibility	Early review reveals degradation or inhibitor risks before cohort processing begins.
Target definition	Gene symbols, transcript IDs, genomic coordinates, BED file, or candidate intervals	Reference assembly version, strand/feature definition, interval padding, and duplicate regions	A confirmed coordinate system prevents probe design and variant annotation from referring to different loci.
Cohort metadata	Sample IDs, populations or groups, species or ancestry information, collection site, and relevant covariates	Balanced groups, missing fields, batch structure, and permitted comparisons	Well-structured metadata allows QC and population summaries to answer the planned biological comparisons.
Discovery evidence	Prior WGS, WES, GWAS, QTL, literature, or pilot results	How each target was nominated and which variants or regions require follow-up	Traceable target selection keeps the panel aligned with the original discovery question.

Population-Level Bioinformatics Analysis

Bioinformatics converts focused reads into cohort-ready evidence. The minimum workflow evaluates read quality, alignment, target performance, and variants; optional modules extend the dataset into allele-frequency, haplotype, population-comparison, or association-ready outputs when the study design supports them.

Read and alignment QC: sample-level summaries reveal low-quality data, unexpected mapping behavior, or batch imbalance, so problematic samples can be reviewed before cohort conclusions are drawn.
Target coverage and callability: per-region and per-sample summaries identify loci that are consistently evaluable, helping researchers avoid comparing groups at positions with unequal evidence.
SNP and small-indel processing: variants are represented in VCF-compatible outputs with filters and supporting fields, so downstream review can distinguish retained calls from excluded or uncertain sites.
Variant annotation: assembly-aware gene and feature annotation links sequence changes to the targeted biological context, reducing manual interpretation across large variant tables.
Allele-frequency summaries: counts and frequencies can be organized by population or study group, allowing direct comparison of common and rare variation within the agreed sampling design.
Regional haplotype analysis: when marker density, phase information, and study design are suitable, region-level haplotypes can summarize combinations of nearby variants that single-site tables miss.
Population comparison or association-ready datasets: harmonized genotype and metadata files can be prepared for downstream analysis, reducing reformatting while preserving documented filters and exclusions.

Representative Analysis Outputs

Representative visuals should make both technical quality and biological interpretation visible. A useful demo set includes a target-coverage heatmap, per-sample callability or missingness summary, allele-frequency comparison, regional variant view, haplotype-frequency plot, and an optional association or population-differentiation view. Final plot types depend on the agreed scope; illustrative figures must not be interpreted as guaranteed project results.

Illustrative targeted resequencing results with coverage heatmap, allele-frequency comparison, regional variants, and haplotype summaries. Figure 4: Illustrative analysis views show how target performance and population-level findings can be reviewed together.

What You Receive

Deliverables are scoped around reuse: raw data support reprocessing, processed files support variant review, and cohort summaries support biological interpretation. Providing these layers together means technical teams can audit the analysis while investigators can move directly to the population-level questions.

Sequencing data: FASTQ files, with aligned BAM or CRAM files when included in scope, allow independent reprocessing and locus-level review.
Variant datasets: VCF files and filtered variant tables preserve sample genotypes, site filters, and supporting annotations for downstream work.
Target and coverage QC: on-target, coverage, uniformity, callability, and missingness summaries show which samples and regions support reliable cohort comparison.
Population summaries: allele counts and frequency tables by agreed group make common and rare variation easier to compare.
Regional results: haplotype or region-level summaries can be delivered when supported by the data and study design.
Analysis-ready outputs: population-comparison or association-ready files can be prepared according to the confirmed scope.
Methods and analysis report: documented references, filters, QC observations, and figure explanations help the project team interpret and reproduce the work.

When Targeted Resequencing Fits a Population Study

This approach is strongest when discovery has already narrowed the genomic search space and the next question requires more samples, more consistent coverage of nominated regions, or both. The common thread is a defined target set and a population-level decision.

GWAS and QTL Follow-Up

Associated loci or mapped intervals can be resequenced across an expanded cohort to identify additional variants and refine regional evidence. This connects broad discovery with focused validation, so researchers can prioritize candidate variants without repeating a full-genome survey.

Candidate-Gene and Regulatory-Region Studies

Known genes, promoters, enhancers, or conserved elements can be studied together even when they are dispersed across the genome. A single coordinated design keeps the target definition consistent across samples, which is particularly useful for multi-population comparisons.

Rare-Variant Discovery in Defined Regions

Concentrating reads on selected loci can increase evidence for low-frequency variants within those regions. The benefit is narrower, more reviewable candidate lists, although detection capability still depends on sequencing allocation, DNA quality, local sequence context, and cohort size.

Cross-Population Validation and Breeding Research

Variants nominated in one population can be tested in additional populations, breeding materials, or geographic groups. This reveals whether candidate alleles are shared, population-specific, or associated with distinct regional haplotypes.

Case Study: Custom Target Capture for Wild Mouse Population Genomics

From chip to SNP: Rapid development and evaluation of a targeted capture genotyping-by-sequencing approach to support research and management of a plaguing rodent

Journal: PLOS ONE

Published: 2023

Oh KP, Van de Weyer N, Ruscoe WA, Henry S, Brown PR. From chip to SNP: Rapid development and evaluation of a targeted capture genotyping-by-sequencing approach to support research and management of a plaguing rodent. PLOS ONE. 2023;18(8):e0288701.

The researchers needed a flexible SNP genotyping approach for wild house-mouse populations that could support population assignment, kinship analysis, and continued monitoring. An existing array contained many markers that were uninformative for the focal wild populations, creating a clear need for a population-specific target set.

Array data from mice sampled across southeastern Australia were used to select informative SNPs for a custom hybridization-capture panel. The final design targeted 3,651 SNPs, and the researchers applied it to 320 mice before conducting sequencing QC, genotype comparison, principal-component analysis, discriminant analysis, population assignment, and kinship inference.

After quality filtering, 317 samples and 3,565 targeted SNPs were retained. For 47 samples measured by both methods, 98.9% of called genotypes were concordant. The targeted dataset distinguished mice from two adjoining farms and achieved a mean population-assignment rate of 0.955 in the study's cross-validation procedure.

Figure 5: Original case-study summary of the cohort, custom target capture workflow, and population-genetic findings reported by Oh et al. (2023).

This study shows how a target set derived from prior discovery data can support focused population analysis in a larger follow-up cohort. It also illustrates an important boundary: a panel optimized for one population may require redesign before use in a different population, because marker informativeness and ascertainment bias can change.

Targeted Resequencing vs WGS, WES, and SNP Genotyping

Method selection should begin with the research question, not with a preferred technology. Targeted resequencing is usually the best fit when the regions are already known and sequence-level variant discovery must scale across a large cohort; broader or fixed-marker methods are more appropriate when the question falls outside that boundary.

Decision Factor	Targeted Resequencing	WGS	WES	SNP Genotyping
Best starting point	Known genes, loci, intervals, or coordinates	Open-ended genome-wide discovery	Coding-exon discovery	Known, predefined markers
Variant scope	Sequence variants within custom targets	Genome-wide sequence variants	Variants mainly in annotated exons	Alleles represented on the marker set
Noncoding targets	Can be included by design, helping studies test regulatory hypotheses	Included genome-wide, supporting discovery beyond known regions	Usually limited, so it may miss a regulatory-region question	Only included when a marker was predefined
Data volume	Focused, reducing storage and review burden per sample	Largest, providing breadth at higher analysis burden	Intermediate, focused on coding sequence	Compact genotype matrix, but no de novo sequence discovery
Large-cohort role	Follow-up, validation, regional discovery, and population comparison	Broad discovery when targets are not yet known	Exonic discovery when coding variation is the priority	Efficient testing of an established marker set
Key limitation	Cannot interrogate regions excluded from the design	More data than a targeted question may require	Does not represent most noncoding regions	Cannot discover variants absent from the marker panel

Best For / Not For

Best for: studies with a defensible gene or region list, a suitable reference assembly, and a need to examine the same targets across many individuals. The method is especially useful after WGS, GWAS, QTL mapping, or pilot sequencing has already identified where to look.

Not the best choice for: open-ended discovery when the relevant genomic regions are still unknown. In that situation, Whole Genome Re-sequencing for Population Genetics may be more appropriate. If the question is limited to coding exons, Whole Exome Sequencing for Population Genetics may provide a more standardized scope. If only established markers are required and new variant discovery is unnecessary, the SNP Genotyping Service may be a better fit.

Why CD Genomics for Large-Cohort Targeted Resequencing

Confidence in a population-scale targeted sequencing project comes from decisions that remain traceable from target selection through cohort-level delivery. CD Genomics connects target-design review, method selection, cohort QC, and bioinformatics scope, helping project teams understand not only what will be done, but why each decision matters for the final comparison.

Research-question-led target review: gene lists, GWAS loci, QTL intervals, and custom coordinates are reviewed against the reference assembly and intended analysis. This reduces the risk of building a technically valid design that does not answer the study's biological question.

Method selection with explicit boundaries: hybridization capture and amplicon targeting are assessed against target architecture, cohort scale, and sequence context. If WGS, WES, or SNP genotyping is a better fit, the comparison is made before the project is locked into a targeted workflow.

Cohort-aware QC instead of isolated sample metrics: target callability, coverage distribution, missingness, and cross-batch consistency are reviewed across samples and groups. This helps prevent technical imbalance from being interpreted as population variation.

Traceable, reusable outputs: sequencing files, variant datasets, QC summaries, population tables, and analysis notes are connected to the agreed methods and filters. Technical teams can audit the work while investigators can move into downstream interpretation with fewer undocumented steps.

Any platform, depth, input, or performance specification not confirmed for the individual project remains subject to feasibility review. This transparency is part of the service design: difficult targets and method limitations should be identified before they become unexplained gaps in a large cohort.

FAQs

How should I define targets for a targeted resequencing project?

You can begin with gene symbols, transcript identifiers, genomic coordinates, a BED file, GWAS loci, QTL intervals, or prior variant results. Always include the reference assembly version and explain how each target relates to the study objective. This lets feasibility review detect coordinate mismatches, repetitive regions, or missing interval context before design.

Is there a minimum or maximum target size?

There is no useful universal limit because feasibility depends on the number and length of intervals, genome complexity, repeats, GC composition, homology, sample count, and the targeting method. A compact amplicon design and a broad hybrid-capture design solve different problems, so target size should be evaluated together with the cohort and expected analysis.

How is sequencing coverage selected?

Coverage is planned from the variant classes, expected allele frequencies, ploidy, target architecture, sample quality, and acceptable missingness. The key decision is not a generic depth number; it is whether the planned evidence can support the intended variant and cohort comparison. The project plan should therefore define both sequencing allocation and QC interpretation.

Do I need a reference genome?

A suitable reference assembly is normally needed for coordinate-based design, read alignment, and variant annotation. If the focal species lacks a high-quality reference, a related assembly, transcriptome, prior amplicons, or de novo sequence resource may sometimes support a modified strategy, but uncertainty and cross-species divergence must be evaluated before design.

Can you use targets discovered by another laboratory or from my existing data?

Yes. Existing WGS, WES, GWAS, QTL, VCF, or pilot results can be used to nominate targets when the reference assembly, coordinates, and supporting evidence are provided. External results are reviewed rather than assumed to be directly design-ready, which reduces errors caused by outdated assemblies or ambiguous feature definitions.

Can targeted resequencing support population frequencies and haplotypes?

It can support allele-frequency summaries when sampling groups, genotype QC, and callable sites are defined consistently. Regional haplotype analysis may also be possible when marker density and phase information are adequate. These analyses should be planned before sequencing because cohort balance, metadata, and target spacing affect what can be inferred.

Use Variant Calling Service when the primary need is consistent variant processing from existing sequencing data. For discovery-stage population studies, explore the Genome-wide Association Analysis Service or QTL Location Analysis Service; their results can provide the loci and intervals for a later targeted resequencing study.

Next step: assemble the target list, reference assembly, sample count, population groups, existing discovery evidence, and desired outputs. These inputs allow a technical review to determine whether capture, amplicon targeting, WGS, WES, or SNP genotyping best matches the project.

References

Mamanova L, Coffey AJ, Scott CE, et al. Target-enrichment strategies for next-generation sequencing. Nature Methods. 2010;7(2):111-118. View article by DOI.
Li X, Liu X, Fan Y, et al. Development of a target capture sequencing SNP genotyping platform for genetic analysis and genomic breeding in rapeseed. The Crop Journal. 2023;11(2):499-510. View article by DOI.
Oh KP, Van de Weyer N, Ruscoe WA, Henry S, Brown PR. From chip to SNP: Rapid development and evaluation of a targeted capture genotyping-by-sequencing approach to support research and management of a plaguing rodent. PLOS ONE. 2023;18(8):e0288701. View article by DOI.
Leonard SR, Mammel MK, Gharizadeh B, et al. Development of a targeted amplicon sequencing method for genotyping Cyclospora cayetanensis from fresh produce and clinical samples with enhanced genomic resolution and sensitivity. Frontiers in Microbiology. 2023;14:1212863. View article by DOI.
Han Y, Gu S, Zhu M, et al. Development and application of a genotyping by target sequencing single-nucleotide polymorphism array panel in Salix suchowensis. BMC Genomics. 2026;27(1):355. View article by DOI.

* Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.